Back to Search
SHAKER DAKHIL, MD
MD
Hematology & Oncology Physician
NPI: 1417918079IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
0418826(KS)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
OTHER
Class of 1975
Research & Publications (20)
Randomized phase II trial of gemcitabine plus weekly versus three-weekly paclitaxel in previously untreated advanced non-small-cell lung cancer.
PMID 17043094·Ann Oncol·2007
3-trial
Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8.
PMID 19468757·Support Care Cancer·2010
4-observational
Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer.
PMID 19075278·J Clin Oncol·2009
3-trial
Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831.
PMID 19349549·J Clin Oncol·2009
3-trial
Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124.
PMID 19349543·J Clin Oncol·2009
3-trial
Effects of therapeutic massage on the quality of life among patients with breast cancer during treatment.
PMID 19388859·J Altern Complement Med·2009
3-trial
Melanoma metastatic to the duodenum presenting as upper GI bleed: 2 cases and a review of the literature.
PMID 18241862·Gastrointest Endosc·2008
5-case
Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897.
PMID 18227530·J Clin Oncol·2008
4-observational
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial.
PMID 18250349·J Clin Oncol·2008
3-trial
Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.
PMID 18258986·J Clin Oncol·2008
4-observational
Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: phase II results from the North Central Cancer Treatment Group (N044B).
PMID 18449005·J Thorac Oncol·2008
3-trial
Southwest Oncology Group phase II study of ispinesib in androgen-independent prostate cancer previously treated with taxanes.
PMID 18824433·Clin Genitourin Cancer·2008
3-trial
Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500).
PMID 17696203·Am J Hematol·2007
3-trial
Von Meyenberg complexes simulating diffuse liver metastasis in rectal carcinoma.
PMID 17767438·Med J Aust·2007
5-case
A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group.
PMID 17320666·Urology·2007
3-trial
Impact of a peer-delivered telephone intervention for women experiencing a breast cancer recurrence.
PMID 17513815·J Clin Oncol·2007
3-trial
A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group.
PMID 17674351·Cancer·2007
2-rct
Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention.
PMID 17290726·Mayo Clin Proc·2007
4-observational
Interleukin-1 genetic polymorphisms and their relationship to the cancer anorexia/weight loss syndrome in metastatic gastric and gastroesophageal junction adenocarcinoma.
PMID 17265786·J Support Oncol·2007
8-other
Topotecan and paclitaxel in previously treated patients with relapsed small cell lung cancer: phase II trial of the North Central Cancer Treatment Group.
PMID 17409859·J Thorac Oncol·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 818 N EMPORIA ST, SUITE 403
WICHITA, KS 67214 - Phone
- (316) 262-4467
Quick Facts
- NPI
- 1417918079
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 51
- Publications
- 20
Are you this provider?
Claim Your Profile